Literature DB >> 30629898

Febrile Neutropenia: An Ounce of Prevention or a Pound of Cure.

Gary H Lyman1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30629898     DOI： 10.1200/JOP.18.00750

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  2 in total

1.  Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients.

Authors:  Spinel Karas; Amy S Etheridge; Deborah A Nickerson; Nancy J Cox; Karen L Mohlke; Erika Cecchin; Giuseppe Toffoli; Ron H J Mathijssen; Alan Forrest; Robert R Bies; Federico Innocenti
Journal:  Br J Cancer       Date:  2021-10-26       Impact factor: 9.075

2.  Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.

Authors:  Lee S Schwartzberg; Gajanan Bhat; Julio Peguero; Richy Agajanian; Jayaram S Bharadwaj; Alvaro Restrepo; Osama Hlalah; Inderjit Mehmi; Shanta Chawla; Steven J Hasal; Zane Yang; Patrick Wayne Cobb
Journal:  Oncologist       Date:  2020-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.